About the Engagement
Stenvall Skoeld & Company Limited (SSCO) provided valuation services and assessment of potential Chinese partners in combination with Tissuemed’s acquisition by BD.
Tissuemed is based in Leeds, UK. The company’s lead product, Tissuepatch™, is a proprietary sealant technology that bonds to tissue to help control internal bleeding or prevent leaks from surgical incisions. The technology’s thin, flexible and transparent composition that is ready to use out of the package makes it ideally suited for a range of surgical sealant applications.